Related references
Note: Only part of the references are listed.The identification and management of heparin-induced thrombocytopenia in the vascular patient
Glenn M. LaMuraglia et al.
JOURNAL OF VASCULAR SURGERY (2012)
Impact of dabigatran on a large panel of routine or specific coagulation assays Laboratory recommendations for monitoring of dabigatran etexilate
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves
Stephen H. McKellar et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood
C. Carrieri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system
Taketoshi Furugohri et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha(2)-macroglobulin-thrombin
R. J. Wagenvoord et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Critical Factors Contributing to the Thromboelastography Trace
Stephen G. MacDonald et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis
Shu He et al.
THROMBOSIS AND HAEMOSTASIS (2010)
New insights into the molecular mechanisms of the fibrinolytic system
D. C. Rijken et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban
G. T. Gerotziafas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dabigatran/dabigatran etexilate -: Prevention of DVT prevention of ischemic stroke thrombin inhibitor
LA Sorbera et al.
DRUGS OF THE FUTURE (2005)
Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models
T Furugohri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Bivalent direct thrombin inhibitors: hirudin and bivalirudin
TE Warkentin
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets
LO Mosnier et al.
BLOOD (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin
SM Bates et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
